|
|
|
|
Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines purchased from
outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations and other pharmaceutical companies. It has a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in Somerset, New Jersey and is involved in manufacturing, product development, and administrative activities related to its ophthalmic and hospital drugs & injectables segments. The Company operates in four segments: ophthalmic, hospital drugs & injectables, biologics & vaccines and contract services.
.
( Total: 9 Current Stock Recommendations )
|
|
|
|
Filter by Gains:
Show:
|
|
|
Rating:
Buy AKRX
10.85 %
|
Rating:
Buy AKRX
15.72 %
|
Rating:
Hold AKRX
6.17 %
|
Rating:
Buy AKRX
6.53 %
|
Rating:
Buy AKRX
33.64 %
|
Rating:
Buy AKRX
6.17 %
|
Rating:
Buy AKRX
33.64 %
|
Rating:
Buy AKRX
60.93 %
|
Rating:
Buy AKRX
60.93 %
|
Rating:
Buy AKRX
354.54 %
|
Rating:
Buy AKRX
354.54 %
|
Rating:
Buy AKRX
647.42 %
|
Rating:
Buy AKRX
119.03 %
|
|
|
|
|
Your Recent Stocks
|
| Symbol | Last | Change |
|
AKRX
| 14.50 |
0.34 %
|
|
|